"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
InformNNY on MSN5h
CNY man is first patient in US to receive new prostate cancer treatmentOn March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate ...
The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...
Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...
The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell ...
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...
Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new ...
Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, depression, type 2 diabetes, and prostate cancer less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback